Escherichia coli strain Nissle 1917 (Mutaflor®,) enteric coated hard capsule finished product (probiotic)

E. coli strain Nissle 1917 is of human origin. It fulfills all microbiological and molecular biological safety requirements.
In the field of gastgroenterology it is

• used maintain the remission stage of ulcerative colitis
• and to treat patients with chronic constipation.

The product quality is amongs others, characterized by its microbiological purity and the defined high number of viable cell in each chard capsule.
The pharmaceutical form of a enteric coated hard caplsule allows, that high numbers of E. coli Nissle bacteria can reach the intestinal tract in a viable state.
CTD is available.

Live Biotherapeutic Product (LBP)